Primary refractory plasmablastic lymphoma: A precision oncology approach

Primary refractory plasmablastic lymphoma: A precision oncology approach

IntroductionHematologic malignancies are currently underrepresented in multidisciplinary molecular-tumor-boards (MTB). This study assesses the potential of precision-oncology in primary-refractory plasmablastic-lymphoma (prPBL), a highly lethal blood cancer.MethodsWe evaluated clinicopathological an...

Full description

Bibliographic Details
Main Authors: Hanno M. Witte, Anke Fähnrich, Axel Künstner, Jörg Riedl, Stephanie M. J. Fliedner, Niklas Reimer, Nadine Hertel, Nikolas von Bubnoff, Veronica Bernard, Hartmut Merz, Hauke Busch, Alfred Feller, Niklas Gebauer
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
molecular tumor board
plasmablastic lymphoma
whole exome sequencing
whole transcriptome sequencing
recurrent aberrations
targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1129405/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1129405/full

Similar Items